Orlando, Fla., Nov. 26 - Valensa International and Parry Nutraceuticals (Division of E.I.D. Parry (India) Ltd., Chennai, India), as part of a growth strategy for both companies, have joined forces to usher in the next generation of high-performance nutritional products from plant-derived sources for the condition-specific dietary supplement, functional food and fortified beverage sectors.
EID Parry acquired a 48% strategic stake in U.S. Nutraceuticals doing business as Valensa International. Valensa's "Direct to Marketers" product development and business strategy will be expanded under a new management team led by Valensa's President, Dr. Rudi E. Moerck, which includes executives from both companies. With the Valensa investment, Parry becomes a marketing partner and a strategic source of botanical materials and technology for new and existing Valensa products in the fast-growing areas of Omega-3 Essential Fatty Acids (ALA, EPA and DHA); phycocyanins and carotenoids including astaxanthin, lycopene, lutein, zeaxanthin; and others. The new arrangement will strengthen Valensa's ability to market its science-based products globally. Current areas of co-marketing between the companies include astaxanthin and Valensa's patented SpiruZan(TM), a Spirulina/Astaxanthin product co-launched by the two companies at Natural Products Expo East in Boston and HI Europe in Paris.
According to Dr. Rudi E. Moerck, the companies have the same philosophies on sustainable natural product production and focus on natural ingredients made using environmentally responsible technology such as Valensa's organic-certified supercritical carbon dioxide extraction plant in Florida, USA. "Parry Nutraceuticals shares Valensa International's commitment to creating the highest-quality products based on the best available science for the condition-specific human health and nutrition market," he said. "Parry Nutraceuticals is one of the leading producers of ultra-high-quality raw materials including organic Spirulina and carotenoids like beta carotene, astaxanthin, lutein and tomato lycopene. Our cooperative new product development work with Parry will allow us to accelerate our new product development efforts to deliver some of the most exciting new products to the market," he added.
Two Leaders Working Together
Valensa and Parry recently introduced a new dietary supplement, SpiruZan(TM) -- a synergistic complex of micro-algae-based organic Spirulina and Astaxanthin in a small, easy-to-swallow 500 mg caplet presentation. SpiruZan combines the well-known nutritional properties of organic Spirulina with the superior antioxidant properties of Astaxanthin to deliver a "brain+body" supplement that offers enhanced protection from both dietary and environmental stress factors. SpiruZan is now available, providing 1 mg astaxanthin in an organic Spirulina serving. Spirulina product line extensions are also planned.
Parry Nutraceuticals produces the only GRAS-certified Spirulina that is also certified under USDA NOP, OCIA-IFOAM, Naturland and ECOCERT organic standards. Valensa's ingredients are manufactured using the company's DeepExtract(TM) High Pressure Supercritical CO2 Extraction and O2B(TM) Peroxidation Blocker technology, yielding more of the micronutrients contained in natural botanical materials and protecting both products and people from the problems associated with oxidation and rancidification.